Biotechnology ResearchWashington, United States51-200 Employees
We have merged with Sobi AB creating a biopharma company positioned to provide innovative medicines that transform the lives of people with rare and debilitating diseases. Visit www.sobi.com to continue to learn more about our work. For more information on the acquisition, see our press release at: https://bit.ly/42XKW9M
| CTI BioPharma Email Formats | Percentage |
| FLast@ctibiopharma.com | 94% |
| Last@ctibiopharma.com | 4% |
| First.Last@ctibiopharma.com | 1% |
| FirstLast@ctibiopharma.com | 1% |
| First.Last@sobi.com | 98% |
| First.MiddleLast@sobi.com | 1% |
| FirstMiddle.Last@sobi.com | 1% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| FLast@ctibiopharma.com | 94% |
| Last@ctibiopharma.com | 4% |
| First.Last@ctibiopharma.com | 1% |
| FirstLast@ctibiopharma.com | 1% |
| First.Last@sobi.com | 98% |
| First.MiddleLast@sobi.com | 1% |
| FirstMiddle.Last@sobi.com | 1% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com